Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05497453
What this trial is testing

Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene

Who this might be right for
Hepatocellular CarcinomaSolid TumorHepatocellular Carcinoma Non-resectable+4 more
Omega Therapeutics 24
Early research (Phase 1)Active Not RecruitingNCT04947241
What this trial is testing

Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCC

Who this might be right for
Locally Advanced Head and Neck Squamous Cell CarcinomaNeoadjuvant Therapy
Fifth Affiliated Hospital, Sun Yat-Sen University 20
Not applicableNot Yet RecruitingNCT07388095
What this trial is testing

Adebrelimab Neoadjuvant Treatment for Resectable ESCC

Who this might be right for
ESCC
Tianjin Medical University Cancer Institute and Hospital 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06851169
What this trial is testing

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Alone or Combined with Anlotinib Administered Prior to Surgery in Terms of Pathological Complete Response

Who this might be right for
Non Small Cell Lung Cancer
Tang-Du Hospital 58
Testing effectiveness (Phase 2)UnknownNCT05007145
What this trial is testing

PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal NeoplasmsEsophageal Squamous Cell Carcinoma
Fujian Cancer Hospital 92
Large-scale testing (Phase 3)Study completedNCT00002839
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 564
Testing effectiveness (Phase 2)Active Not RecruitingNCT06465329
What this trial is testing

Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Regeneron Pharmaceuticals 120
Post-approval studies (Phase 4)Ended earlyNCT01887041
What this trial is testing

Quality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas Cancer

Who this might be right for
Local Tumor SpreadAdvanced CancerMetastasized+2 more
Universitätsklinikum Hamburg-Eppendorf 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05151588
What this trial is testing

Induction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal Carcinoma

Who this might be right for
Sinonasal Carcinoma
Dr. Victor H.F. Lee 30
Testing effectiveness (Phase 2)UnknownNCT04834986
What this trial is testing

Tislelizumab Combined With Lenvatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma

Who this might be right for
Resectable Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT02685631
What this trial is testing

Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study

Who this might be right for
Localized Non-Resectable Adult Liver Carcinoma
Vanderbilt-Ingram Cancer Center 1,653
Early research (Phase 1)Study completedNCT01040559
What this trial is testing

Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas

Who this might be right for
Carcinoma, Hepatocellular
Centre Hospitalier Universitaire Dijon 18
Testing effectiveness (Phase 2)UnknownNCT05389527
What this trial is testing

Pembrolizumab and Lenvatinib for Resectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Zhongshan Hospital 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07684040
What this trial is testing

Combination Therapy in Patients With Resectable Liver Cancer

Who this might be right for
Liver Cancer (Primary and Metastatic)
Affiliated Hospital of Guangdong Medical University 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT05343325
What this trial is testing

The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaNeoadjuvant Treatment
Fifth Affiliated Hospital, Sun Yat-Sen University 25
Testing effectiveness (Phase 2)Ended earlyNCT03574818
What this trial is testing

Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001

Who this might be right for
Squamous Cell Lung Cancer
Montefiore Medical Center 1
Testing effectiveness (Phase 2)Study completedNCT02676349
What this trial is testing

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

Who this might be right for
Pancreatic Carcinoma
Institut de Cancérologie de Lorraine 130
Testing effectiveness (Phase 2)UnknownNCT00973778
What this trial is testing

Short Preoperative Chemoradiotherapy for Resectable Rectal Carcinoma

Who this might be right for
Chemoradiotherapy
Shanghai Jiao Tong University School of Medicine 62
Early research (Phase 1)WithdrawnNCT07100925
What this trial is testing

Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)Renal TransplantSolid Tumor+1 more
Ankyra Therapeutics, Inc
Testing effectiveness (Phase 2)Study completedNCT04930315
What this trial is testing

SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 78
Next Page